Neuroscience
Eicosanoid Receptor
65%
Bradykinin
37%
Agonist
34%
Sensory Neuron
22%
Ligand
22%
In Vivo
21%
5-HT2C Receptor
20%
δ -Opioid Receptor
19%
Arachidonic Acid
17%
Serotonin
14%
Neuron
12%
Enkephalin
10%
Estrogens
10%
Inverse Agonist
10%
Kappa Opiate Receptor
10%
Protein Kinase C
10%
In Vitro
10%
Κ-opioid receptor
9%
Nociceptor
9%
Phospholipase C
9%
Trigeminal Ganglion
9%
Inositol Phosphate
8%
Opioid
8%
Cell Signaling
8%
Receptor Agonists
8%
Allodynia
8%
Norbinaltorphimine
7%
Adenylyl Cyclase
7%
Kinase
7%
Amino Terminal Sequence
7%
Functional Selectivity
7%
Receptor Subtype
6%
Dopamine Release
6%
Dopamine
6%
Phospholipase A2
6%
Extracellular Signal-Regulated Kinases
6%
5-HT1A Receptor
5%
Prostaglandin E2
5%
Inverse Agonism
5%
Brain
5%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Agonist
32%
Bradykinin
28%
Ligand
26%
Arachidonic Acid
22%
Serotonin
18%
Opiate Receptor
16%
Rat
15%
Desensitization
15%
Antagonist
14%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
13%
Protein Kinase C
13%
Adenylate Cyclase
11%
Drug
11%
Heteromer
11%
Inverse Agonist
10%
Inositol Phosphate
10%
Enkephalin
10%
Functional Selectivity
9%
Phospholipase A2
8%
Naloxone
7%
Receptor Subtype
7%
Serotonin 2C Receptor
7%
Thermal Allodynia
7%
Norbinaltorphimine
7%
Chinese Hamster
6%
Phospholipase C
6%
Forskolin
5%
Dopamine
5%
Phosphotransferase
5%
Proteinase Activated Receptor 2
5%
Delta Opiate Receptor
5%
Calcium
5%
Drug Development
5%
Prostaglandin E2
5%
Medicine and Dentistry
Receptor
61%
Agonist
23%
Ligand
20%
Neuron
11%
Selectivity
9%
Inverse Agonist
9%
Chemotherapeutic Agent
9%
Drug
9%
Receptor Subtype
8%
Bradykinin
8%
Inverse Agonism
7%
In Vitro
7%
Therapeutic Procedure
7%
Inositol Phosphate
7%
Signal Transduction
7%
Cells
6%
Pain
6%
Ganglion
6%
κ-Opioid Receptor
5%
Blood Transfusion
5%
Combination Therapy
5%
Patient
5%
Brain
5%
Dopamine
5%
Proteinase Activated Receptor 2
5%
